Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Australian Clinical Labs.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Integral goes big in Queensland, Credit Suisse says it’s time to choose between HLS and ACL
News
December ASX Winners Column: Health and telco stocks plus recapitalised resources companies won the month
News
Here are the top ASX large cap movers for Tuesday
Health & Biotech
Australian Clinical Labs still raking in the cash from COVID tests; upgrades its guidance again
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: Emyria to create wearable device for psychedelics, while Telix gets FDA nod
Health & Biotech
ASX Health Stocks: Mesoblast jumps 10pc on Phase 3 trial results for chronic heart failure
Health & Biotech
ASX Health Stocks: Mach7 jumps 6.5pc on US sales, while large cap health companies slump
Health & Biotech
Australian Clinical Labs flags revenue boost, amid a surge in COVID-19 testing demand
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Reporting Season Round Up: Swoop and Fineos lead the best performers on the ASX today
Health & Biotech
ASX Health Stocks: Acrux flags testosterone solution with an armpit application, Clinuvel posts record revenues
News
Trading Places: Which fund manager just became a substantial shareholder of Nuix?
Health & Biotech
Investors have struggled to find long term money makers from COVID, but has this sector been the one all along?
News
Fresh listee Lynch Group shares rise after upgrading its guidance for FY21
News
Last Orders: Another big gain in energy shares leads the ASX to a positive closing
IPO Watch
